Relapsed/Refractory Classical Hodgkins Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Classical Hodgkins Lymphoma
| Record | Firm | Date |
|---|---|---|
| AZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHL (NCT05140382) | AstraZeneca | 2021-12-15 |
Track Relapsed/Refractory Classical Hodgkins Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.